Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases

Changes in the oxidative status of erythrocytes can reduce cell lifetime, oxygen transport, and delivery capacity to peripheral tissues and have been associated with a plethora of human diseases. Among reactive oxygen and nitrogen species of importance in red blood cell (RBC) homeostasis, superoxide and nitric oxide radicals play a key role. In the present work, we evaluated subcellular effects induced by peroxynitrite, the product of the fast reaction between superoxide and nitric oxide. Peroxynitrite induced 1) oxidation of oxyhemoglobin to methemoglobin, 2) cytoskeleton rearrangement, 3) ultrastructural alterations, and 4) altered expression of band‐3 and decreased expression of glycophorin A. With respect to control cells, this occurred in a significantly higher percentage of human RBC (∼40%). The presence of antioxidants inhibited these modifications. Furthermore, besides these senescence‐associated changes, other important modifications, absent in control RBC and usually associated with apoptotic cell death, were detected in a small but significant subset of peroxynitrite‐exposed RBC (∼7%). Active protease cathepsin E and μ‐calpain increased; activation of caspase 2 and caspase 3 was detected; and phosphatidylserine externalization, an early marker of apoptosis, was observed. Conversely, inhibition of cathepsin E, μ‐calpain, as well as caspase 2 and 3 by specific inhibitors resulted in a significant impairment of erythrocyte “apoptosis.” Altogether, these results indicate that peroxynitrite, a milestone of redox‐mediated damage in human pathology, can hijack human RBC toward senescence and apoptosis by a mechanism involving both cysteinyl and aspartyl proteases.

[1]  J. Bastacky,et al.  Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia. , 2001, Blood.

[2]  M. Dachá,et al.  Intracellular flavonoids as electron donors for extracellular ferricyanide reduction in human erythrocytes. , 2002, Free radical biology & medicine.

[3]  P. Matarrese,et al.  N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease. , 2000, Biochemical and biophysical research communications.

[4]  J. Poderoso,et al.  Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils , 1994, FEBS letters.

[5]  W. Malorni,et al.  Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine. , 2002, Biochemical and biophysical research communications.

[6]  J. Estaquier,et al.  Molecular and Cellular Mechanisms of Erythrocyte Programmed Cell Death: Impact on Blood Transfusion , 2002, Vox sanguinis.

[7]  Joyoti Basu,et al.  Caspase 3-mediated Proteolysis of the N-terminal Cytoplasmic Domain of the Human Erythroid Anion Exchanger 1 (Band 3)* , 2003, Journal of Biological Chemistry.

[8]  P. Matarrese,et al.  CD95 (APO‐1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway , 2000, The EMBO journal.

[9]  M. Peter,et al.  Differences between CD95 type I and type II cells detected with the CD95 ligand [1] , 1999 .

[10]  V. Fadok,et al.  Loss of Phospholipid Asymmetry and Surface Exposure of Phosphatidylserine Is Required for Phagocytosis of Apoptotic Cells by Macrophages and Fibroblasts* , 2001, The Journal of Biological Chemistry.

[11]  J. Davoust,et al.  Asymmetric lateral mobility of phospholipids in the human erythrocyte membrane. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Zografi,et al.  The interaction of lung annexin I with phospholipid monolayers at the air/water interface. , 1998, Biochimica et biophysica acta.

[13]  C. Winterbourn [26] Oxidative reactions of hemoglobin , 1990 .

[14]  E. Zaino PATHOPHYSIOLOGY OF THALASSEMIA , 1980, Annals of the New York Academy of Sciences.

[15]  R. Rossi,et al.  Protein thiols and glutathione influence the nitric oxide-dependent regulation of the red blood cell metabolism. , 2002, Nitric oxide : biology and chemistry.

[16]  G. Kroemer,et al.  Erythrocytes: Death of a mummy , 2001, Cell Death and Differentiation.

[17]  C. Winterbourn Oxidative reactions of hemoglobin. , 1990, Methods in enzymology.

[18]  F. Kuypers Phospholipid asymmetry in health and disease , 1998, Current opinion in hematology.

[19]  L. Kanz,et al.  Enhanced Erythrocyte Apoptosis in Sickle Cell Anemia, Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency , 2002, Cellular Physiology and Biochemistry.

[20]  S. Ohnishi,et al.  Heterogeneity in the fluidity of intact erythrocyte membrane and its homogenization upon hemolysis. , 1976, Biochimica et biophysica acta.

[21]  N. Mohandas,et al.  Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Y. Bilto,et al.  Effects of selected flavonoids on deformability, osmotic fragility and aggregation of human erythrocytes. , 1998, Clinical hemorheology and microcirculation.

[23]  S. Fucharoen,et al.  Hemin: A Possible Cause of Oxidative Stress in Blood Circulation of β-Thalassemia/Hemoglobin E Disease , 2003, Free radical research.

[24]  L. G. Korkina,et al.  Congenital disorders sharing oxidative stress and cancer proneness as phenotypic hallmarks: prospects for joint research in pharmacology. , 1998, Medical hypotheses.

[25]  M. Neri,et al.  Analysis of Erythrocyte Glycophorin-A Variants by Flow Cytometry in Lung Disease Patients Detects the Effect of Tobacco Smoke , 2000, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[26]  A. Schroit,et al.  Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. , 1994, The Journal of biological chemistry.

[27]  C. Brugnara,et al.  Pathophysiological-based approaches to treatment of sickle cell disease. , 2003, Annual review of medicine.

[28]  R. Radi,et al.  Diffusion of peroxynitrite across erythrocyte membranes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Matarrese,et al.  Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function. , 2002, The American journal of pathology.

[30]  P. Moitra,et al.  Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes , 2002, FEBS letters.

[31]  C. Saldanha,et al.  Nitric oxide effects on human erythrocytes structural and functional properties--an in vitro study. , 2002, Clinical hemorheology and microcirculation.

[32]  D. Discher,et al.  Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. , 1996, Blood.

[33]  A. Brovelli,et al.  Oxidation state of glutathione and membrane proteins in human red cells of different age , 1995, Mechanisms of Ageing and Development.

[34]  P. Williamson,et al.  Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. H. Engels,et al.  Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis , 2001, Cell Death and Differentiation.

[36]  D. Schubert,et al.  Cytoskeleton-membrane connections in the human erythrocyte membrane: band 4.1 binds to tetrameric band 3 protein. , 1997, Biochimica et biophysica acta.

[37]  M. T. Santini,et al.  Junctional sites of erythrocyte skeletal proteins are specific targets of tert-butylhydroperoxide oxidative damage. , 1995, Chemico-biological interactions.

[38]  G. Buonocore,et al.  Iron release, oxidative stress and erythrocyte ageing. , 2002, Free radical biology & medicine.

[39]  P. Low,et al.  The interaction of hemoglobin with the cytoplasmic domain of band 3 of the human erythrocyte membrane. , 1984, The Journal of biological chemistry.

[40]  L. G. Korkina,et al.  Cytoskeleton alterations of erythrocytes from patients with Fanconi's anemia , 2000, FEBS letters.

[41]  P. Matarrese,et al.  Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress , 2002, Journal of neurochemistry.

[42]  F. Lang,et al.  Cation channels, cell volume and the death of an erythrocyte , 2003, Pflügers Archiv.

[43]  F. Boas,et al.  Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Mallozzi,et al.  Peroxynitrite modulates tyrosine‐dependent signal transduction pathway of human erythrocyte band 3 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  A. Larsson,et al.  Oxidative stress in inborn errors of metabolism: Lessons from glutathione deficiency , 2002, Journal of Inherited Metabolic Disease.

[46]  C. Slomianny,et al.  Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria , 2001, Cell Death and Differentiation.

[47]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[48]  J. Mazur,et al.  PEROXYNITRITE ACTIVATES K+‐Cl−COTRANSPORT IN HUMAN ERYTHROCYTES , 2001, Cell biology international.

[49]  F. Kuypers,et al.  Altered red cell turnover in diabetic mice. , 2002, The Journal of laboratory and clinical medicine.

[50]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[51]  S. G. Grant,et al.  Diagnosis of ataxia telangiectasia with the glycophorin A somatic mutation assay. , 1997, Genetic testing.

[52]  Z. Eshhar,et al.  Calpain (Ca(2+)-dependent thiol protease) in erythrocytes of young and old individuals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Tanner,et al.  Heterologous expression of the red-cell anion exchanger (band 3; AE1). , 1999, Biochemical Society Transactions.

[54]  T. Seyama,et al.  In vivo somatic mutations in Werner’s syndrome , 1998, Human Genetics.

[55]  N. Mohandas,et al.  Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure. , 2002, Experimental hematology.

[56]  Clinton H Joiner,et al.  Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. , 2003, Blood.

[57]  W. Pryor,et al.  The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. , 1995, The American journal of physiology.

[58]  J. Vincent,et al.  Alterations of red blood cell shape and sialic acid membrane content in septic patients , 2003, Critical care medicine.

[59]  R. Radi,et al.  Diffusion of peroxynitrite in the presence of carbon dioxide. , 1999, Archives of biochemistry and biophysics.

[60]  J. Poole Red cell antigens on band 3 and glycophorin A. , 2000, Blood reviews.

[61]  A. Al-Mehdi,et al.  Peroxynitrite‐mediated oxidative protein modifications , 1995, FEBS letters.

[62]  L. D. Robb-Gaspers,et al.  Coordination of calcium signalling by endothelial-derived nitric oxide in the intact liver , 1999, Nature Cell Biology.

[63]  L. Snyder,et al.  Oxidation and erythrocyte senescence. , 2000, Current opinion in hematology.

[64]  P. Williamson,et al.  Phosphatidylserine, a death knell , 2001, Cell Death and Differentiation.

[65]  J S Beckman,et al.  Peroxynitrite formation from macrophage-derived nitric oxide. , 1992, Archives of biochemistry and biophysics.

[66]  D. Gibson,et al.  Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. , 1996, Blood.

[67]  DE Johnson,et al.  Noncaspase proteases in apoptosis , 2000, Leukemia.

[68]  M. Peter,et al.  Differences between CD95 type I and II cells detected with the CD95 ligand. , 1999, Cell death and differentiation.

[69]  K. Shirato,et al.  Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. , 2000, American journal of respiratory and critical care medicine.

[70]  S. Ohnishi,et al.  Membrane Abnormalities in Sickle Cell Disease and in Other Red Blood Cell Disorders , 1993 .

[71]  N. Thornberry,et al.  Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death , 1996, The Journal of experimental medicine.